» Articles » PMID: 8718522

Genetics and Malignant Progression of Human Brain Tumours

Overview
Journal Cancer Surv
Specialty Oncology
Date 1995 Jan 1
PMID 8718522
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Progression of gliomas to more malignant phenotypes involves numerous molecular genetic alterations. The genes affected by these alterations, the steps in malignant progression for which they are responsible, their normal function in controlling diverse cellular functions such as differentiation, signal transduction, cell cycle progression and angiogenesis and how they may act in concert with other tumour suppressor genes or oncogenes are some of the questions finally coming into focus and being studied. As other genes are discovered, their association with tumour progression can be assessed, coupled with current histopathology and used to determine more accurately patient prognosis and strategies for intervention. With the generation of specific reagents, such as monoclonal antibodies directed to glioma derived antigens or emerging gene therapy techniques designed to deliver toxic, antisense or reconstituting genes specifically to tumour tissue, new approaches will be devised that may finally be used to treat these tumours effectively.

Citing Articles

Differential Effects of MicroRNAs on Glioblastoma Growth and Migration.

Jeansonne D, Pacifici M, Lassak A, Reiss K, Russo G, Zabaleta J Genes (Basel). 2014; 4(1):46-64.

PMID: 24705102 PMC: 3899955. DOI: 10.3390/genes4010046.


EphB4 is overexpressed in gliomas and promotes the growth of glioma cells.

Chen T, Liu X, Yi S, Zhang J, Ge J, Liu Z Tumour Biol. 2012; 34(1):379-85.

PMID: 23138393 DOI: 10.1007/s13277-012-0560-7.


CCL5, CCR1 and CCR5 in murine glioblastoma: immune cell infiltration and survival rates are not dependent on individual expression of either CCR1 or CCR5.

Pham K, Luo D, Liu C, Harrison J J Neuroimmunol. 2012; 246(1-2):10-7.

PMID: 22425022 PMC: 3335967. DOI: 10.1016/j.jneuroim.2012.02.009.


PDGF in gliomas: more than just a growth factor?.

Lindberg N, Holland E Ups J Med Sci. 2012; 117(2):92-8.

PMID: 22376240 PMC: 3339541. DOI: 10.3109/03009734.2012.654860.


Angiogenesis factors in gliomas: a new key to tumour therapy?.

Mentlein R, Held-Feindt J Naturwissenschaften. 2003; 90(9):385-94.

PMID: 14504780 DOI: 10.1007/s00114-003-0449-9.